Table 4 Stage distributions of EC under the screening and nonscreening scenarios
From: Modeling the Cost-effectiveness of Esophageal Cancer Screening in China
Stage | Nonscreening (%) | Screening (%) | Distribution | ||
|---|---|---|---|---|---|
Proportion | SA range | Proportion | SA range | ||
IC | 3.65 | 2.92–4.38 | 88.24 | 70.59–100.00 | Dirichlet |
SM | 4.93 | 3.94–5.92 | 2.52 | 2.02–3.02 | |
Mod | 66.06 | 52.85–79.27 | 6.72 | 5.38–8.06 | |
Adv | 25.36 | 20.29–30.43 | 2.52 | 2.02–3.02 | |